Compare Quest Diagnostics Inc (DGX) vs Reddit Inc (RDDT) Price & Performance

Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.

The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.

RDDT trades at $160.63, up 5.14% over 24 hours, with a bullish technical signal supported by moving averages. The company demonstrates strong profitability, with a net income margin of 31.35% and consecutive quarterly EPS beats. Recent news includes a partnership with Zefr for advertiser insights and a legal win against Anthropic, though concerns arise from the CEO's stock sale and the discontinuation of RSS feeds.

The outlook is positive, supported by robust earnings growth and a consensus price target of $202.52, implying significant upside. Key risks include competitive pressures in social media, potential regulatory scrutiny, and market volatility. Institutional ownership trends and analyst buy ratings (65.52%) reinforce a constructive view, but investors should monitor execution on growth initiatives.